nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—Benzphetamine—obesity	0.165	1	CrCtD
Modafinil—narcolepsy—Methamphetamine—obesity	0.0827	0.533	CpDpCtD
Modafinil—Increased Sympathetic Activity—Diethylpropion—obesity	0.067	0.187	CiPCiCtD
Modafinil—Increased Sympathetic Activity—Phentermine—obesity	0.067	0.187	CiPCiCtD
Modafinil—Increased Sympathetic Activity—Phendimetrazine—obesity	0.067	0.187	CiPCiCtD
Modafinil—Increased Sympathetic Activity—Benzphetamine—obesity	0.067	0.187	CiPCiCtD
Modafinil—Increased Sympathetic Activity—Methamphetamine—obesity	0.0508	0.141	CiPCiCtD
Modafinil—Central Nervous System Stimulation—Methamphetamine—obesity	0.0403	0.112	CiPCiCtD
Modafinil—attention deficit hyperactivity disorder—Bupropion—obesity	0.0363	0.234	CpDpCtD
Modafinil—attention deficit hyperactivity disorder—Methamphetamine—obesity	0.0363	0.234	CpDpCtD
Modafinil—SLC6A3—Diethylpropion—obesity	0.0188	0.128	CbGbCtD
Modafinil—SLC6A3—Sibutramine—obesity	0.0143	0.0971	CbGbCtD
Modafinil—SLC6A3—Phendimetrazine—obesity	0.0143	0.0971	CbGbCtD
Modafinil—Tropicamide—Benzphetamine—obesity	0.0118	0.0976	CrCrCtD
Modafinil—ADRA1B—Phendimetrazine—obesity	0.0114	0.0778	CbGbCtD
Modafinil—SLC6A3—Phentermine—obesity	0.0108	0.0736	CbGbCtD
Modafinil—SLC6A3—Benzphetamine—obesity	0.0108	0.0736	CbGbCtD
Modafinil—SLC6A3—Phenylpropanolamine—obesity	0.0103	0.0702	CbGbCtD
Modafinil—SLC6A3—Bupropion—obesity	0.00919	0.0626	CbGbCtD
Modafinil—SLC6A3—Methamphetamine—obesity	0.00864	0.0588	CbGbCtD
Modafinil—Oxaprozin—Benzphetamine—obesity	0.00679	0.056	CrCrCtD
Modafinil—Phenytoin—Benzphetamine—obesity	0.00679	0.056	CrCrCtD
Modafinil—Phenylbutazone—Benzphetamine—obesity	0.00651	0.0537	CrCrCtD
Modafinil—Isopropamide—Benzphetamine—obesity	0.00624	0.0515	CrCrCtD
Modafinil—Alverine—Benzphetamine—obesity	0.00624	0.0515	CrCrCtD
Modafinil—Phenprocoumon—Benzphetamine—obesity	0.00601	0.0495	CrCrCtD
Modafinil—Benzatropine—Benzphetamine—obesity	0.00579	0.0477	CrCrCtD
Modafinil—Eprazinone—Benzphetamine—obesity	0.0054	0.0445	CrCrCtD
Modafinil—Antazoline—Benzphetamine—obesity	0.0054	0.0445	CrCrCtD
Modafinil—Methadyl Acetate—Benzphetamine—obesity	0.00522	0.0431	CrCrCtD
Modafinil—Levomethadyl Acetate—Benzphetamine—obesity	0.00522	0.0431	CrCrCtD
Modafinil—CYP2B6—Benzphetamine—obesity	0.00491	0.0334	CbGbCtD
Modafinil—Phenoxybenzamine—Benzphetamine—obesity	0.00429	0.0354	CrCrCtD
Modafinil—Dextropropoxyphene—Benzphetamine—obesity	0.00429	0.0354	CrCrCtD
Modafinil—CYP2B6—Bupropion—obesity	0.00417	0.0284	CbGbCtD
Modafinil—Diphenylpyraline—Benzphetamine—obesity	0.00408	0.0337	CrCrCtD
Modafinil—Atomoxetine—Benzphetamine—obesity	0.00408	0.0337	CrCrCtD
Modafinil—Fentanyl—Benzphetamine—obesity	0.00382	0.0315	CrCrCtD
Modafinil—Benzphetamine—Methamphetamine—obesity	0.00378	0.0312	CrCrCtD
Modafinil—Pheniramine—Benzphetamine—obesity	0.00374	0.0308	CrCrCtD
Modafinil—Cyclizine—Benzphetamine—obesity	0.00366	0.0302	CrCrCtD
Modafinil—Methadone—Benzphetamine—obesity	0.00359	0.0296	CrCrCtD
Modafinil—Orphenadrine—Benzphetamine—obesity	0.003	0.0247	CrCrCtD
Modafinil—CYP1A2—Phentermine—obesity	0.00288	0.0196	CbGbCtD
Modafinil—Benzyl Benzoate—Benzphetamine—obesity	0.00278	0.0229	CrCrCtD
Modafinil—CYP1A2—Phenylpropanolamine—obesity	0.00275	0.0187	CbGbCtD
Modafinil—Diphenhydramine—Benzphetamine—obesity	0.00266	0.022	CrCrCtD
Modafinil—CYP2C9—Phentermine—obesity	0.00259	0.0177	CbGbCtD
Modafinil—CYP1A2—Bupropion—obesity	0.00245	0.0167	CbGbCtD
Modafinil—CYP3A5—Cimetidine—obesity	0.00241	0.0164	CbGbCtD
Modafinil—CYP2C9—Bupropion—obesity	0.0022	0.015	CbGbCtD
Modafinil—CYP3A4—Sibutramine—obesity	0.00199	0.0135	CbGbCtD
Modafinil—CYP2C19—Cimetidine—obesity	0.00195	0.0133	CbGbCtD
Modafinil—CYP1A2—Cimetidine—obesity	0.0018	0.0122	CbGbCtD
Modafinil—CYP2C9—Cimetidine—obesity	0.00162	0.011	CbGbCtD
Modafinil—CYP3A4—Benzphetamine—obesity	0.00151	0.0103	CbGbCtD
Modafinil—CYP3A4—Bupropion—obesity	0.00128	0.00873	CbGbCtD
Modafinil—CYP2C19—Topiramate—obesity	0.00127	0.00867	CbGbCtD
Modafinil—CYP3A4—Orlistat—obesity	0.00105	0.00711	CbGbCtD
Modafinil—CYP3A4—Cimetidine—obesity	0.000941	0.00641	CbGbCtD
Modafinil—CYP3A4—Topiramate—obesity	0.000616	0.00419	CbGbCtD
Modafinil—Atomoxetine—NPY1R—obesity	0.000109	0.194	CrCbGaD
Modafinil—Bifonazole—CYP19A1—obesity	3.65e-05	0.0645	CrCbGaD
Modafinil—Levomethadyl Acetate—CYP19A1—obesity	2.74e-05	0.0485	CrCbGaD
Modafinil—Bifonazole—CYP2E1—obesity	2.72e-05	0.0481	CrCbGaD
Modafinil—Myalgia—Orlistat—obesity	2.69e-05	0.000754	CcSEcCtD
Modafinil—Chest pain—Orlistat—obesity	2.69e-05	0.000754	CcSEcCtD
Modafinil—Loss of consciousness—Sibutramine—obesity	2.69e-05	0.000753	CcSEcCtD
Modafinil—Mental disorder—Bupropion—obesity	2.68e-05	0.000752	CcSEcCtD
Modafinil—Urinary retention—Topiramate—obesity	2.68e-05	0.000752	CcSEcCtD
Modafinil—Anxiety—Orlistat—obesity	2.68e-05	0.000751	CcSEcCtD
Modafinil—Mood swings—Topiramate—obesity	2.67e-05	0.000749	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	2.67e-05	0.000749	CcSEcCtD
Modafinil—Phenoxybenzamine—SLC22A1—obesity	2.67e-05	0.0473	CrCbGaD
Modafinil—Cough—Sibutramine—obesity	2.67e-05	0.000748	CcSEcCtD
Modafinil—Malnutrition—Bupropion—obesity	2.67e-05	0.000747	CcSEcCtD
Modafinil—Discomfort—Orlistat—obesity	2.66e-05	0.000745	CcSEcCtD
Modafinil—Ataxia—Topiramate—obesity	2.65e-05	0.000743	CcSEcCtD
Modafinil—Convulsion—Sibutramine—obesity	2.65e-05	0.000743	CcSEcCtD
Modafinil—Hypertension—Sibutramine—obesity	2.64e-05	0.00074	CcSEcCtD
Modafinil—Dry mouth—Orlistat—obesity	2.63e-05	0.000737	CcSEcCtD
Modafinil—Flatulence—Bupropion—obesity	2.63e-05	0.000736	CcSEcCtD
Modafinil—Tension—Bupropion—obesity	2.62e-05	0.000733	CcSEcCtD
Modafinil—Dysgeusia—Bupropion—obesity	2.61e-05	0.000732	CcSEcCtD
Modafinil—Arthralgia—Sibutramine—obesity	2.6e-05	0.00073	CcSEcCtD
Modafinil—Chest pain—Sibutramine—obesity	2.6e-05	0.00073	CcSEcCtD
Modafinil—Myalgia—Sibutramine—obesity	2.6e-05	0.00073	CcSEcCtD
Modafinil—Anxiety—Sibutramine—obesity	2.59e-05	0.000727	CcSEcCtD
Modafinil—Nervousness—Bupropion—obesity	2.59e-05	0.000726	CcSEcCtD
Modafinil—Oedema—Orlistat—obesity	2.58e-05	0.000723	CcSEcCtD
Modafinil—Anaphylactic shock—Orlistat—obesity	2.58e-05	0.000723	CcSEcCtD
Modafinil—Back pain—Bupropion—obesity	2.58e-05	0.000723	CcSEcCtD
Modafinil—Abdominal pain upper—Topiramate—obesity	2.58e-05	0.000722	CcSEcCtD
Modafinil—Discomfort—Sibutramine—obesity	2.57e-05	0.000721	CcSEcCtD
Modafinil—Muscle spasms—Bupropion—obesity	2.56e-05	0.000718	CcSEcCtD
Modafinil—Infection—Orlistat—obesity	2.56e-05	0.000718	CcSEcCtD
Modafinil—Nepafenac—PTGS2—obesity	2.56e-05	0.0453	CrCbGaD
Modafinil—Dry mouth—Sibutramine—obesity	2.55e-05	0.000714	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Topiramate—obesity	2.54e-05	0.000712	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Topiramate—obesity	2.54e-05	0.000712	CcSEcCtD
Modafinil—Nervous system disorder—Orlistat—obesity	2.53e-05	0.000709	CcSEcCtD
Modafinil—Confusional state—Sibutramine—obesity	2.52e-05	0.000705	CcSEcCtD
Modafinil—Skin disorder—Orlistat—obesity	2.51e-05	0.000702	CcSEcCtD
Modafinil—Tremor—Bupropion—obesity	2.5e-05	0.0007	CcSEcCtD
Modafinil—Anaphylactic shock—Sibutramine—obesity	2.5e-05	0.0007	CcSEcCtD
Modafinil—Oedema—Sibutramine—obesity	2.5e-05	0.0007	CcSEcCtD
Modafinil—Hyperhidrosis—Orlistat—obesity	2.49e-05	0.000699	CcSEcCtD
Modafinil—Muscular weakness—Topiramate—obesity	2.49e-05	0.000697	CcSEcCtD
Modafinil—Infection—Sibutramine—obesity	2.48e-05	0.000695	CcSEcCtD
Modafinil—Ill-defined disorder—Bupropion—obesity	2.47e-05	0.000693	CcSEcCtD
Modafinil—Anaemia—Bupropion—obesity	2.46e-05	0.000691	CcSEcCtD
Modafinil—Shock—Sibutramine—obesity	2.46e-05	0.000688	CcSEcCtD
Modafinil—Agitation—Bupropion—obesity	2.45e-05	0.000687	CcSEcCtD
Modafinil—Asthma—Topiramate—obesity	2.44e-05	0.000683	CcSEcCtD
Modafinil—Angioedema—Bupropion—obesity	2.44e-05	0.000683	CcSEcCtD
Modafinil—Tachycardia—Sibutramine—obesity	2.44e-05	0.000683	CcSEcCtD
Modafinil—Skin disorder—Sibutramine—obesity	2.42e-05	0.00068	CcSEcCtD
Modafinil—Eosinophilia—Topiramate—obesity	2.41e-05	0.000677	CcSEcCtD
Modafinil—Hyperhidrosis—Sibutramine—obesity	2.41e-05	0.000676	CcSEcCtD
Modafinil—Malaise—Bupropion—obesity	2.4e-05	0.000674	CcSEcCtD
Modafinil—Vertigo—Bupropion—obesity	2.4e-05	0.000671	CcSEcCtD
Modafinil—Syncope—Bupropion—obesity	2.39e-05	0.00067	CcSEcCtD
Modafinil—Anorexia—Sibutramine—obesity	2.38e-05	0.000667	CcSEcCtD
Modafinil—Atomoxetine—HTR1B—obesity	2.38e-05	0.0421	CrCbGaD
Modafinil—Palpitations—Bupropion—obesity	2.36e-05	0.00066	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Orlistat—obesity	2.35e-05	0.000659	CcSEcCtD
Modafinil—Bronchitis—Topiramate—obesity	2.34e-05	0.000657	CcSEcCtD
Modafinil—Loss of consciousness—Bupropion—obesity	2.34e-05	0.000657	CcSEcCtD
Modafinil—Insomnia—Orlistat—obesity	2.33e-05	0.000654	CcSEcCtD
Modafinil—Hypotension—Sibutramine—obesity	2.33e-05	0.000654	CcSEcCtD
Modafinil—Cough—Bupropion—obesity	2.33e-05	0.000652	CcSEcCtD
Modafinil—Paraesthesia—Orlistat—obesity	2.32e-05	0.000649	CcSEcCtD
Modafinil—Pancytopenia—Topiramate—obesity	2.32e-05	0.000649	CcSEcCtD
Modafinil—Convulsion—Bupropion—obesity	2.31e-05	0.000647	CcSEcCtD
Modafinil—Hypertension—Bupropion—obesity	2.3e-05	0.000645	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Sibutramine—obesity	2.27e-05	0.000637	CcSEcCtD
Modafinil—Dyspepsia—Orlistat—obesity	2.27e-05	0.000636	CcSEcCtD
Modafinil—Chest pain—Bupropion—obesity	2.27e-05	0.000636	CcSEcCtD
Modafinil—Arthralgia—Bupropion—obesity	2.27e-05	0.000636	CcSEcCtD
Modafinil—Myalgia—Bupropion—obesity	2.27e-05	0.000636	CcSEcCtD
Modafinil—Anxiety—Bupropion—obesity	2.26e-05	0.000634	CcSEcCtD
Modafinil—Insomnia—Sibutramine—obesity	2.26e-05	0.000633	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	2.25e-05	0.000632	CcSEcCtD
Modafinil—Pollakiuria—Topiramate—obesity	2.25e-05	0.000631	CcSEcCtD
Modafinil—Erectile dysfunction—Topiramate—obesity	2.25e-05	0.000629	CcSEcCtD
Modafinil—Discomfort—Bupropion—obesity	2.24e-05	0.000629	CcSEcCtD
Modafinil—Decreased appetite—Orlistat—obesity	2.24e-05	0.000628	CcSEcCtD
Modafinil—Paraesthesia—Sibutramine—obesity	2.24e-05	0.000628	CcSEcCtD
Modafinil—Diphenhydramine—SLC22A1—obesity	2.24e-05	0.0396	CrCbGaD
Modafinil—Gastrointestinal disorder—Orlistat—obesity	2.23e-05	0.000624	CcSEcCtD
Modafinil—Dyspnoea—Sibutramine—obesity	2.23e-05	0.000624	CcSEcCtD
Modafinil—Photosensitivity reaction—Topiramate—obesity	2.23e-05	0.000624	CcSEcCtD
Modafinil—Fatigue—Orlistat—obesity	2.22e-05	0.000623	CcSEcCtD
Modafinil—Dry mouth—Bupropion—obesity	2.22e-05	0.000622	CcSEcCtD
Modafinil—Somnolence—Sibutramine—obesity	2.22e-05	0.000622	CcSEcCtD
Modafinil—Weight increased—Topiramate—obesity	2.22e-05	0.000622	CcSEcCtD
Modafinil—Weight decreased—Topiramate—obesity	2.21e-05	0.000618	CcSEcCtD
Modafinil—Pain—Orlistat—obesity	2.21e-05	0.000618	CcSEcCtD
Modafinil—Hyperglycaemia—Topiramate—obesity	2.2e-05	0.000616	CcSEcCtD
Modafinil—Dyspepsia—Sibutramine—obesity	2.2e-05	0.000616	CcSEcCtD
Modafinil—Confusional state—Bupropion—obesity	2.19e-05	0.000615	CcSEcCtD
Modafinil—Pneumonia—Topiramate—obesity	2.19e-05	0.000613	CcSEcCtD
Modafinil—Anaphylactic shock—Bupropion—obesity	2.18e-05	0.00061	CcSEcCtD
Modafinil—Oedema—Bupropion—obesity	2.18e-05	0.00061	CcSEcCtD
Modafinil—Decreased appetite—Sibutramine—obesity	2.17e-05	0.000608	CcSEcCtD
Modafinil—Depression—Topiramate—obesity	2.17e-05	0.000607	CcSEcCtD
Modafinil—Infection—Bupropion—obesity	2.16e-05	0.000606	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Topiramate—obesity	2.16e-05	0.000604	CcSEcCtD
Modafinil—Gastrointestinal disorder—Sibutramine—obesity	2.15e-05	0.000604	CcSEcCtD
Modafinil—Shock—Bupropion—obesity	2.14e-05	0.0006	CcSEcCtD
Modafinil—Pain—Sibutramine—obesity	2.13e-05	0.000598	CcSEcCtD
Modafinil—Constipation—Sibutramine—obesity	2.13e-05	0.000598	CcSEcCtD
Modafinil—Nervous system disorder—Bupropion—obesity	2.13e-05	0.000598	CcSEcCtD
Modafinil—Oxaprozin—PTGS2—obesity	2.13e-05	0.0377	CrCbGaD
Modafinil—Feeling abnormal—Orlistat—obesity	2.13e-05	0.000596	CcSEcCtD
Modafinil—Tachycardia—Bupropion—obesity	2.12e-05	0.000595	CcSEcCtD
Modafinil—Stomatitis—Topiramate—obesity	2.12e-05	0.000594	CcSEcCtD
Modafinil—Skin disorder—Bupropion—obesity	2.11e-05	0.000592	CcSEcCtD
Modafinil—Conjunctivitis—Topiramate—obesity	2.11e-05	0.000592	CcSEcCtD
Modafinil—Urinary tract infection—Topiramate—obesity	2.11e-05	0.000592	CcSEcCtD
Modafinil—Gastrointestinal pain—Orlistat—obesity	2.11e-05	0.000591	CcSEcCtD
Modafinil—Hyperhidrosis—Bupropion—obesity	2.1e-05	0.00059	CcSEcCtD
Modafinil—Anorexia—Bupropion—obesity	2.07e-05	0.000581	CcSEcCtD
Modafinil—Haematuria—Topiramate—obesity	2.07e-05	0.000581	CcSEcCtD
Modafinil—Feeling abnormal—Sibutramine—obesity	2.06e-05	0.000577	CcSEcCtD
Modafinil—Epistaxis—Topiramate—obesity	2.05e-05	0.000575	CcSEcCtD
Modafinil—Urticaria—Orlistat—obesity	2.05e-05	0.000574	CcSEcCtD
Modafinil—Gastrointestinal pain—Sibutramine—obesity	2.04e-05	0.000572	CcSEcCtD
Modafinil—Sinusitis—Topiramate—obesity	2.04e-05	0.000572	CcSEcCtD
Modafinil—Body temperature increased—Orlistat—obesity	2.04e-05	0.000571	CcSEcCtD
Modafinil—Abdominal pain—Orlistat—obesity	2.04e-05	0.000571	CcSEcCtD
Modafinil—Hypotension—Bupropion—obesity	2.03e-05	0.00057	CcSEcCtD
Modafinil—Agranulocytosis—Topiramate—obesity	2.03e-05	0.000569	CcSEcCtD
Modafinil—Bradycardia—Topiramate—obesity	1.99e-05	0.000557	CcSEcCtD
Modafinil—Urticaria—Sibutramine—obesity	1.98e-05	0.000556	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Bupropion—obesity	1.98e-05	0.000556	CcSEcCtD
Modafinil—Body temperature increased—Sibutramine—obesity	1.97e-05	0.000553	CcSEcCtD
Modafinil—Abdominal pain—Sibutramine—obesity	1.97e-05	0.000553	CcSEcCtD
Modafinil—Fosphenytoin—ALB—obesity	1.97e-05	0.0349	CrCbGaD
Modafinil—Insomnia—Bupropion—obesity	1.97e-05	0.000552	CcSEcCtD
Modafinil—Rhinitis—Topiramate—obesity	1.96e-05	0.000548	CcSEcCtD
Modafinil—Paraesthesia—Bupropion—obesity	1.95e-05	0.000548	CcSEcCtD
Modafinil—Hallucination—Topiramate—obesity	1.94e-05	0.000544	CcSEcCtD
Modafinil—Dyspnoea—Bupropion—obesity	1.94e-05	0.000544	CcSEcCtD
Modafinil—Atomoxetine—HTR2C—obesity	1.94e-05	0.0343	CrCbGaD
Modafinil—Pharyngitis—Topiramate—obesity	1.94e-05	0.000543	CcSEcCtD
Modafinil—Somnolence—Bupropion—obesity	1.93e-05	0.000542	CcSEcCtD
Modafinil—Urinary tract disorder—Topiramate—obesity	1.93e-05	0.00054	CcSEcCtD
Modafinil—Oedema peripheral—Topiramate—obesity	1.92e-05	0.000539	CcSEcCtD
Modafinil—Connective tissue disorder—Topiramate—obesity	1.92e-05	0.000537	CcSEcCtD
Modafinil—Dyspepsia—Bupropion—obesity	1.92e-05	0.000537	CcSEcCtD
Modafinil—Urethral disorder—Topiramate—obesity	1.91e-05	0.000536	CcSEcCtD
Modafinil—Hypersensitivity—Orlistat—obesity	1.9e-05	0.000533	CcSEcCtD
Modafinil—Decreased appetite—Bupropion—obesity	1.89e-05	0.00053	CcSEcCtD
Modafinil—Visual impairment—Topiramate—obesity	1.88e-05	0.000527	CcSEcCtD
Modafinil—Gastrointestinal disorder—Bupropion—obesity	1.88e-05	0.000527	CcSEcCtD
Modafinil—Fatigue—Bupropion—obesity	1.88e-05	0.000526	CcSEcCtD
Modafinil—Constipation—Bupropion—obesity	1.86e-05	0.000522	CcSEcCtD
Modafinil—Pain—Bupropion—obesity	1.86e-05	0.000522	CcSEcCtD
Modafinil—Asthenia—Orlistat—obesity	1.85e-05	0.000519	CcSEcCtD
Modafinil—Erythema multiforme—Topiramate—obesity	1.85e-05	0.000517	CcSEcCtD
Modafinil—Hypersensitivity—Sibutramine—obesity	1.84e-05	0.000515	CcSEcCtD
Modafinil—Pruritus—Orlistat—obesity	1.82e-05	0.000511	CcSEcCtD
Modafinil—Cardiac disorder—Topiramate—obesity	1.81e-05	0.000508	CcSEcCtD
Modafinil—Cinnarizine—DRD2—obesity	1.8e-05	0.0318	CrCbGaD
Modafinil—Feeling abnormal—Bupropion—obesity	1.79e-05	0.000503	CcSEcCtD
Modafinil—Asthenia—Sibutramine—obesity	1.79e-05	0.000502	CcSEcCtD
Modafinil—Gastrointestinal pain—Bupropion—obesity	1.78e-05	0.000499	CcSEcCtD
Modafinil—Angiopathy—Topiramate—obesity	1.77e-05	0.000496	CcSEcCtD
Modafinil—Pruritus—Sibutramine—obesity	1.77e-05	0.000495	CcSEcCtD
Modafinil—Diarrhoea—Orlistat—obesity	1.76e-05	0.000495	CcSEcCtD
Modafinil—Immune system disorder—Topiramate—obesity	1.76e-05	0.000494	CcSEcCtD
Modafinil—Mediastinal disorder—Topiramate—obesity	1.76e-05	0.000493	CcSEcCtD
Modafinil—Fenoprofen—PTGS2—obesity	1.76e-05	0.0311	CrCbGaD
Modafinil—Chills—Topiramate—obesity	1.75e-05	0.000491	CcSEcCtD
Modafinil—Urticaria—Bupropion—obesity	1.73e-05	0.000485	CcSEcCtD
Modafinil—Abdominal pain—Bupropion—obesity	1.72e-05	0.000482	CcSEcCtD
Modafinil—Body temperature increased—Bupropion—obesity	1.72e-05	0.000482	CcSEcCtD
Modafinil—Mental disorder—Topiramate—obesity	1.71e-05	0.000479	CcSEcCtD
Modafinil—Diarrhoea—Sibutramine—obesity	1.71e-05	0.000479	CcSEcCtD
Modafinil—Dizziness—Orlistat—obesity	1.71e-05	0.000478	CcSEcCtD
Modafinil—Phenoxybenzamine—ADRB2—obesity	1.7e-05	0.0302	CrCbGaD
Modafinil—Malnutrition—Topiramate—obesity	1.7e-05	0.000476	CcSEcCtD
Modafinil—Flatulence—Topiramate—obesity	1.67e-05	0.000469	CcSEcCtD
Modafinil—Tension—Topiramate—obesity	1.67e-05	0.000467	CcSEcCtD
Modafinil—Dysgeusia—Topiramate—obesity	1.66e-05	0.000466	CcSEcCtD
Modafinil—Dizziness—Sibutramine—obesity	1.65e-05	0.000463	CcSEcCtD
Modafinil—Nervousness—Topiramate—obesity	1.65e-05	0.000462	CcSEcCtD
Modafinil—Back pain—Topiramate—obesity	1.64e-05	0.000461	CcSEcCtD
Modafinil—Vomiting—Orlistat—obesity	1.64e-05	0.00046	CcSEcCtD
Modafinil—Muscle spasms—Topiramate—obesity	1.63e-05	0.000458	CcSEcCtD
Modafinil—Rash—Orlistat—obesity	1.63e-05	0.000456	CcSEcCtD
Modafinil—Dermatitis—Orlistat—obesity	1.62e-05	0.000455	CcSEcCtD
Modafinil—Headache—Orlistat—obesity	1.62e-05	0.000453	CcSEcCtD
Modafinil—Methadone—CYP19A1—obesity	1.61e-05	0.0284	CrCbGaD
Modafinil—Atomoxetine—SLC6A4—obesity	1.61e-05	0.0284	CrCbGaD
Modafinil—Hypersensitivity—Bupropion—obesity	1.6e-05	0.000449	CcSEcCtD
Modafinil—Tremor—Topiramate—obesity	1.59e-05	0.000446	CcSEcCtD
Modafinil—Vomiting—Sibutramine—obesity	1.59e-05	0.000445	CcSEcCtD
Modafinil—Ill-defined disorder—Topiramate—obesity	1.58e-05	0.000442	CcSEcCtD
Modafinil—Rash—Sibutramine—obesity	1.57e-05	0.000441	CcSEcCtD
Modafinil—Dermatitis—Sibutramine—obesity	1.57e-05	0.000441	CcSEcCtD
Modafinil—Anaemia—Topiramate—obesity	1.57e-05	0.00044	CcSEcCtD
Modafinil—Fenoprofen—ALB—obesity	1.57e-05	0.0277	CrCbGaD
Modafinil—Headache—Sibutramine—obesity	1.56e-05	0.000438	CcSEcCtD
Modafinil—Asthenia—Bupropion—obesity	1.56e-05	0.000438	CcSEcCtD
Modafinil—Agitation—Topiramate—obesity	1.56e-05	0.000438	CcSEcCtD
Modafinil—Pruritus—Bupropion—obesity	1.54e-05	0.000432	CcSEcCtD
Modafinil—Nausea—Orlistat—obesity	1.53e-05	0.000429	CcSEcCtD
Modafinil—Malaise—Topiramate—obesity	1.53e-05	0.000429	CcSEcCtD
Modafinil—Vertigo—Topiramate—obesity	1.53e-05	0.000428	CcSEcCtD
Modafinil—Syncope—Topiramate—obesity	1.52e-05	0.000427	CcSEcCtD
Modafinil—Palpitations—Topiramate—obesity	1.5e-05	0.000421	CcSEcCtD
Modafinil—Loss of consciousness—Topiramate—obesity	1.49e-05	0.000418	CcSEcCtD
Modafinil—Diarrhoea—Bupropion—obesity	1.49e-05	0.000417	CcSEcCtD
Modafinil—Nausea—Sibutramine—obesity	1.48e-05	0.000416	CcSEcCtD
Modafinil—Cough—Topiramate—obesity	1.48e-05	0.000415	CcSEcCtD
Modafinil—Convulsion—Topiramate—obesity	1.47e-05	0.000413	CcSEcCtD
Modafinil—Hypertension—Topiramate—obesity	1.47e-05	0.000411	CcSEcCtD
Modafinil—Myalgia—Topiramate—obesity	1.45e-05	0.000405	CcSEcCtD
Modafinil—Arthralgia—Topiramate—obesity	1.45e-05	0.000405	CcSEcCtD
Modafinil—Chest pain—Topiramate—obesity	1.45e-05	0.000405	CcSEcCtD
Modafinil—Anxiety—Topiramate—obesity	1.44e-05	0.000404	CcSEcCtD
Modafinil—Dizziness—Bupropion—obesity	1.44e-05	0.000403	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	1.44e-05	0.000403	CcSEcCtD
Modafinil—Discomfort—Topiramate—obesity	1.43e-05	0.0004	CcSEcCtD
Modafinil—Dry mouth—Topiramate—obesity	1.41e-05	0.000396	CcSEcCtD
Modafinil—Phenylbutazone—PTGS2—obesity	1.41e-05	0.0249	CrCbGaD
Modafinil—Confusional state—Topiramate—obesity	1.4e-05	0.000392	CcSEcCtD
Modafinil—Oedema—Topiramate—obesity	1.39e-05	0.000389	CcSEcCtD
Modafinil—Vomiting—Bupropion—obesity	1.38e-05	0.000388	CcSEcCtD
Modafinil—Infection—Topiramate—obesity	1.38e-05	0.000386	CcSEcCtD
Modafinil—Rash—Bupropion—obesity	1.37e-05	0.000385	CcSEcCtD
Modafinil—Dermatitis—Bupropion—obesity	1.37e-05	0.000384	CcSEcCtD
Modafinil—Shock—Topiramate—obesity	1.36e-05	0.000382	CcSEcCtD
Modafinil—Headache—Bupropion—obesity	1.36e-05	0.000382	CcSEcCtD
Modafinil—Nervous system disorder—Topiramate—obesity	1.36e-05	0.000381	CcSEcCtD
Modafinil—Tachycardia—Topiramate—obesity	1.35e-05	0.000379	CcSEcCtD
Modafinil—Phenprocoumon—ALB—obesity	1.35e-05	0.0239	CrCbGaD
Modafinil—Skin disorder—Topiramate—obesity	1.35e-05	0.000377	CcSEcCtD
Modafinil—Hyperhidrosis—Topiramate—obesity	1.34e-05	0.000376	CcSEcCtD
Modafinil—Anorexia—Topiramate—obesity	1.32e-05	0.00037	CcSEcCtD
Modafinil—Oxcarbazepine—ALB—obesity	1.31e-05	0.0233	CrCbGaD
Modafinil—Hypotension—Topiramate—obesity	1.3e-05	0.000363	CcSEcCtD
Modafinil—Nausea—Bupropion—obesity	1.29e-05	0.000362	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Topiramate—obesity	1.26e-05	0.000354	CcSEcCtD
Modafinil—Insomnia—Topiramate—obesity	1.25e-05	0.000351	CcSEcCtD
Modafinil—Paraesthesia—Topiramate—obesity	1.24e-05	0.000349	CcSEcCtD
Modafinil—Dyspnoea—Topiramate—obesity	1.24e-05	0.000346	CcSEcCtD
Modafinil—Atomoxetine—HTR2A—obesity	1.23e-05	0.0218	CrCbGaD
Modafinil—Somnolence—Topiramate—obesity	1.23e-05	0.000345	CcSEcCtD
Modafinil—Dyspepsia—Topiramate—obesity	1.22e-05	0.000342	CcSEcCtD
Modafinil—Decreased appetite—Topiramate—obesity	1.21e-05	0.000338	CcSEcCtD
Modafinil—Warfarin—ALB—obesity	1.2e-05	0.0212	CrCbGaD
Modafinil—Gastrointestinal disorder—Topiramate—obesity	1.2e-05	0.000335	CcSEcCtD
Modafinil—Fatigue—Topiramate—obesity	1.2e-05	0.000335	CcSEcCtD
Modafinil—Pain—Topiramate—obesity	1.19e-05	0.000332	CcSEcCtD
Modafinil—Constipation—Topiramate—obesity	1.19e-05	0.000332	CcSEcCtD
Modafinil—Orphenadrine—CYP2E1—obesity	1.17e-05	0.0208	CrCbGaD
Modafinil—Feeling abnormal—Topiramate—obesity	1.14e-05	0.00032	CcSEcCtD
Modafinil—Gastrointestinal pain—Topiramate—obesity	1.13e-05	0.000318	CcSEcCtD
Modafinil—Urticaria—Topiramate—obesity	1.1e-05	0.000309	CcSEcCtD
Modafinil—Abdominal pain—Topiramate—obesity	1.1e-05	0.000307	CcSEcCtD
Modafinil—Body temperature increased—Topiramate—obesity	1.1e-05	0.000307	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—obesity	1.04e-05	0.0184	CrCbGaD
Modafinil—Hypersensitivity—Topiramate—obesity	1.02e-05	0.000286	CcSEcCtD
Modafinil—Asthenia—Topiramate—obesity	9.95e-06	0.000279	CcSEcCtD
Modafinil—Pruritus—Topiramate—obesity	9.81e-06	0.000275	CcSEcCtD
Modafinil—Diarrhoea—Topiramate—obesity	9.49e-06	0.000266	CcSEcCtD
Modafinil—Ketoprofen—ALB—obesity	9.25e-06	0.0164	CrCbGaD
Modafinil—Dizziness—Topiramate—obesity	9.17e-06	0.000257	CcSEcCtD
Modafinil—Vomiting—Topiramate—obesity	8.81e-06	0.000247	CcSEcCtD
Modafinil—Rash—Topiramate—obesity	8.74e-06	0.000245	CcSEcCtD
Modafinil—Dermatitis—Topiramate—obesity	8.73e-06	0.000245	CcSEcCtD
Modafinil—Phenytoin—ALB—obesity	8.7e-06	0.0154	CrCbGaD
Modafinil—Headache—Topiramate—obesity	8.69e-06	0.000243	CcSEcCtD
Modafinil—Nausea—Topiramate—obesity	8.23e-06	0.000231	CcSEcCtD
Modafinil—CYP2C19—Metabolism—NCOA1—obesity	9.25e-07	5.82e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LPIN1—obesity	9.24e-07	5.81e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NQO1—obesity	9.23e-07	5.8e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOE—obesity	9.12e-07	5.74e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LEP—obesity	9.12e-07	5.74e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKR1C3—obesity	9.12e-07	5.73e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—STK11—obesity	9.12e-07	5.73e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP19A1—obesity	9.12e-07	5.73e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—obesity	9.07e-07	5.7e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOA5—obesity	9.05e-07	5.69e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CAV1—obesity	9.04e-07	5.68e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	9.03e-07	5.68e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOA1—obesity	9.02e-07	5.67e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SCARB1—obesity	8.98e-07	5.64e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	8.95e-07	5.63e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARA—obesity	8.9e-07	5.59e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—obesity	8.86e-07	5.57e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	8.86e-07	5.57e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC2A4—obesity	8.84e-07	5.56e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GCG—obesity	8.84e-07	5.56e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	8.74e-07	5.5e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYCS—obesity	8.73e-07	5.49e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SREBF1—obesity	8.72e-07	5.48e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ESR1—obesity	8.71e-07	5.48e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARA—obesity	8.7e-07	5.47e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC22A1—obesity	8.64e-07	5.43e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CLOCK—obesity	8.64e-07	5.43e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AGT—obesity	8.62e-07	5.42e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—F2—obesity	8.6e-07	5.41e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PRKCB—obesity	8.6e-07	5.41e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GGT1—obesity	8.57e-07	5.38e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GOT1—obesity	8.57e-07	5.38e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BAD—obesity	8.5e-07	5.34e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GOT2—obesity	8.48e-07	5.33e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—COMT—obesity	8.48e-07	5.33e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOE—obesity	8.44e-07	5.31e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NCOA1—obesity	8.44e-07	5.3e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AGT—obesity	8.42e-07	5.29e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SULT2A1—obesity	8.42e-07	5.29e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GLP1R—obesity	8.42e-07	5.29e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAV1—obesity	8.37e-07	5.26e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	8.36e-07	5.26e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARGC1A—obesity	8.36e-07	5.26e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GNB3—obesity	8.36e-07	5.26e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOA1—obesity	8.35e-07	5.25e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMOX1—obesity	8.32e-07	5.23e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—STK11—obesity	8.32e-07	5.23e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP19A1—obesity	8.32e-07	5.23e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—FASN—obesity	8.3e-07	5.22e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—DPYD—obesity	8.28e-07	5.2e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BCHE—obesity	8.26e-07	5.19e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOE—obesity	8.25e-07	5.19e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—obesity	8.23e-07	5.18e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAV1—obesity	8.18e-07	5.14e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOA1—obesity	8.16e-07	5.13e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GNAS—obesity	8.14e-07	5.12e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IRS1—obesity	8.14e-07	5.12e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2E1—obesity	7.97e-07	5.01e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOB—obesity	7.97e-07	5.01e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PRKAR2B—obesity	7.97e-07	5.01e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—DCN—obesity	7.91e-07	4.97e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NQO1—obesity	7.88e-07	4.96e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—POMC—obesity	7.84e-07	4.93e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—INS—obesity	7.79e-07	4.9e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—COMT—obesity	7.73e-07	4.86e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	7.72e-07	4.85e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CPT1A—obesity	7.7e-07	4.84e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCL2—obesity	7.67e-07	4.82e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	7.65e-07	4.81e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARGC1A—obesity	7.62e-07	4.79e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GNB3—obesity	7.62e-07	4.79e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—obesity	7.62e-07	4.79e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—LPL—obesity	7.61e-07	4.78e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMOX1—obesity	7.59e-07	4.77e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GCG—obesity	7.56e-07	4.75e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC2A4—obesity	7.56e-07	4.75e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NAMPT—obesity	7.55e-07	4.74e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1—obesity	7.54e-07	4.74e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT2—obesity	7.53e-07	4.74e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LIPC—obesity	7.5e-07	4.72e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GCK—obesity	7.5e-07	4.72e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYCS—obesity	7.46e-07	4.69e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOC3—obesity	7.45e-07	4.69e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—obesity	7.45e-07	4.68e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPX1—obesity	7.43e-07	4.67e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GNAS—obesity	7.42e-07	4.67e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARG—obesity	7.35e-07	4.62e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GGT1—obesity	7.32e-07	4.6e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GOT1—obesity	7.32e-07	4.6e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOB—obesity	7.27e-07	4.57e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—POMC—obesity	7.25e-07	4.56e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CD—obesity	7.24e-07	4.55e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CETP—obesity	7.24e-07	4.55e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CD36—obesity	7.23e-07	4.55e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—INS—obesity	7.21e-07	4.53e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NCOA1—obesity	7.21e-07	4.53e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARG—obesity	7.19e-07	4.52e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	7.17e-07	4.51e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SERPINE1—obesity	7.16e-07	4.5e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SDC1—obesity	7.16e-07	4.5e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—STK11—obesity	7.11e-07	4.47e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP19A1—obesity	7.11e-07	4.47e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—POMC—obesity	7.09e-07	4.46e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—INS—obesity	7.05e-07	4.43e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKR1C3—obesity	7.04e-07	4.43e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TYK2—obesity	6.96e-07	4.38e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—LPL—obesity	6.94e-07	4.36e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SCARB1—obesity	6.93e-07	4.36e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RHOA—obesity	6.91e-07	4.34e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—obesity	6.85e-07	4.31e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOS3—obesity	6.84e-07	4.3e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3R1—obesity	6.84e-07	4.3e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPX1—obesity	6.77e-07	4.26e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SREBF1—obesity	6.73e-07	4.23e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARA—obesity	6.72e-07	4.23e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CD—obesity	6.7e-07	4.21e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—obesity	6.61e-07	4.16e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—COMT—obesity	6.61e-07	4.15e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CD36—obesity	6.59e-07	4.15e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CD—obesity	6.55e-07	4.12e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GOT2—obesity	6.54e-07	4.11e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARGC1A—obesity	6.51e-07	4.1e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GNB3—obesity	6.51e-07	4.1e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AGT—obesity	6.51e-07	4.09e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—obesity	6.51e-07	4.09e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMOX1—obesity	6.48e-07	4.08e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—obesity	6.46e-07	4.06e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—FASN—obesity	6.4e-07	4.03e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOE—obesity	6.38e-07	4.01e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BCHE—obesity	6.38e-07	4.01e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GNAS—obesity	6.34e-07	3.99e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3R1—obesity	6.33e-07	3.98e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NOS3—obesity	6.33e-07	3.98e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAV1—obesity	6.32e-07	3.97e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CB—obesity	6.31e-07	3.97e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MTOR—obesity	6.31e-07	3.97e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOA1—obesity	6.31e-07	3.96e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—obesity	6.25e-07	3.93e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOB—obesity	6.21e-07	3.9e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3R1—obesity	6.18e-07	3.89e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NOS3—obesity	6.18e-07	3.89e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2E1—obesity	6.15e-07	3.87e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARA—obesity	6.13e-07	3.85e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NQO1—obesity	6.08e-07	3.82e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	6.04e-07	3.8e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AGT—obesity	5.94e-07	3.73e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LPL—obesity	5.93e-07	3.73e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—obesity	5.86e-07	3.68e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CB—obesity	5.84e-07	3.67e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GCG—obesity	5.83e-07	3.67e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A4—obesity	5.83e-07	3.67e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOE—obesity	5.82e-07	3.66e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPX1—obesity	5.79e-07	3.64e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—obesity	5.79e-07	3.64e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—obesity	5.77e-07	3.62e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAV1—obesity	5.76e-07	3.62e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—obesity	5.76e-07	3.62e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYCS—obesity	5.76e-07	3.62e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOA1—obesity	5.75e-07	3.62e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CB—obesity	5.71e-07	3.59e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—obesity	5.65e-07	3.55e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GGT1—obesity	5.65e-07	3.55e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GOT1—obesity	5.65e-07	3.55e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CD36—obesity	5.64e-07	3.54e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOA1—obesity	5.56e-07	3.5e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARG—obesity	5.56e-07	3.49e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.51e-07	3.46e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—obesity	5.48e-07	3.45e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP19A1—obesity	5.48e-07	3.45e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—STK11—obesity	5.48e-07	3.45e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—POMC—obesity	5.48e-07	3.45e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—INS—obesity	5.45e-07	3.43e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—obesity	5.34e-07	3.36e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK8—obesity	5.33e-07	3.35e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—obesity	5.32e-07	3.34e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—obesity	5.25e-07	3.3e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARA—obesity	5.24e-07	3.29e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—COMT—obesity	5.1e-07	3.21e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AGT—obesity	5.07e-07	3.19e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARG—obesity	5.07e-07	3.19e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CD—obesity	5.06e-07	3.18e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GNB3—obesity	5.03e-07	3.16e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARGC1A—obesity	5.03e-07	3.16e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMOX1—obesity	5e-07	3.15e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—POMC—obesity	5e-07	3.14e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—obesity	5e-07	3.14e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOE—obesity	4.97e-07	3.13e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—INS—obesity	4.97e-07	3.12e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAV1—obesity	4.93e-07	3.1e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOA1—obesity	4.91e-07	3.09e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GNAS—obesity	4.9e-07	3.08e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—obesity	4.88e-07	3.07e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOB—obesity	4.79e-07	3.01e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3R1—obesity	4.78e-07	3e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NOS3—obesity	4.78e-07	3e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.71e-07	2.96e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CD—obesity	4.62e-07	2.9e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LPL—obesity	4.58e-07	2.88e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—obesity	4.56e-07	2.86e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—obesity	4.53e-07	2.85e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—obesity	4.52e-07	2.84e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—obesity	4.49e-07	2.82e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPX1—obesity	4.47e-07	2.81e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CB—obesity	4.41e-07	2.77e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—obesity	4.37e-07	2.75e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3R1—obesity	4.36e-07	2.74e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NOS3—obesity	4.36e-07	2.74e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CD36—obesity	4.35e-07	2.73e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARG—obesity	4.33e-07	2.72e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—POMC—obesity	4.27e-07	2.68e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—INS—obesity	4.25e-07	2.67e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—obesity	4.12e-07	2.59e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARA—obesity	4.04e-07	2.54e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CB—obesity	4.02e-07	2.53e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—obesity	3.99e-07	2.51e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CD—obesity	3.94e-07	2.48e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AGT—obesity	3.92e-07	2.46e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—obesity	3.89e-07	2.45e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—obesity	3.85e-07	2.42e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOE—obesity	3.84e-07	2.41e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAV1—obesity	3.8e-07	2.39e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOA1—obesity	3.79e-07	2.38e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3R1—obesity	3.72e-07	2.34e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NOS3—obesity	3.72e-07	2.34e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—obesity	3.56e-07	2.24e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—obesity	3.48e-07	2.19e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—obesity	3.46e-07	2.18e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CB—obesity	3.44e-07	2.16e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—obesity	3.41e-07	2.14e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—obesity	3.41e-07	2.14e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARG—obesity	3.34e-07	2.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—POMC—obesity	3.3e-07	2.07e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—INS—obesity	3.28e-07	2.06e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—obesity	3.14e-07	1.98e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CD—obesity	3.04e-07	1.91e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—obesity	3e-07	1.89e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—obesity	2.91e-07	1.83e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3R1—obesity	2.87e-07	1.81e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NOS3—obesity	2.87e-07	1.81e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—obesity	2.84e-07	1.79e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—obesity	2.69e-07	1.69e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CB—obesity	2.65e-07	1.67e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—obesity	2.63e-07	1.65e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—obesity	2.45e-07	1.54e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—obesity	2.2e-07	1.38e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—obesity	2.1e-07	1.32e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—obesity	2e-07	1.26e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—obesity	1.71e-07	1.08e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—obesity	1.62e-07	1.02e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—obesity	1.32e-07	8.31e-06	CbGpPWpGaD
